A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma

NCT03150862 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

116

Enrollment

INDUSTRY

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG: Pamiparib
DRUG: TMZ
RADIATION: Radiation

Sponsor

BeiGene USA, Inc.